DEA to reclassify marijuana as a lower-risk drug, studies say

Medical marijuana growing in a facility in Canada.

Enlarge / Medical marijuana rising in a facility in Canada. (credit score: Getty | Richard Lautens)

The US Drug Enforcement Administration is getting ready to reclassify marijuana to a lower-risk drug class, a significant federal coverage change that’s consistent with suggestions from the US well being division final 12 months. The upcoming transfer was first reported by the Related Press on Tuesday afternoon and has since been confirmed by a number of different shops.

The DEA at present designates marijuana as a Schedule 1 drug, outlined as medicine “with no at present accepted medical use and a excessive potential for abuse.” It places marijuana in league with LSD and heroin. In response to the studies at the moment, the DEA is transferring to reclassify it as a Schedule three drug, outlined as having “a reasonable to low potential for bodily and psychological dependence.” The transfer would place marijuana within the ranks of ketamine, testosterone, and merchandise containing lower than 90 milligrams of codeine.

Marijuana’s rescheduling can be a nod to its potential medical advantages and would shift federal coverage consistent with many states. So far, 38 states have already legalized medical marijuana.

Learn 5 remaining paragraphs | Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *